Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Increased Breast Cancer Survival with Chemoimmunotherapy

A recent clinical trial suggests that the use of chemotherapy and immunotherapy to treat patients with triple-negative breast cancer can prolong survival. Triple-negative breast cancer is the most aggressive and lethal form of cancer due to the lack of treatment options. The estimated survival rate is approximately 18 months. We have previously reported on what we know about breast cancer biomarkers and a new potential breast cancer treatment. The Phase III trial involved the combined use of a chemotherapy drug (nab-paclitaxel) and a checkpoint inhibitor (atezolizumab) that prolonged survival rates.



What is chemoimmunotherapy?
Chemoimmunotherapy is the combination of both chemotherapy with immunotherapy treatment. Chemotherapy is the use of drugs to prevent the growth of cancer cells while immunotherapy is used to activate or suppress the immune system to destroy tumors.
The trial enrolled patients with cancer that could not be surgically removed. Researchers found a significant prolonged survival increase in patients treated with the combined treatment. Additionally, patients that expressed the programmed death ligand 1 (PD-L1) protein on immune cells that infiltrate the tumor had an increased prolonged survival rate. Targeting PD-1 and PD-L1 may lead to improved treatment of triple-negative breast cancer. The results suggest that patients who are positive for PD-L1 may now have a greater chance of a prolonged survival rate with the combination treatment. Further chemoimmnuotherapy combination treatments could also be tested.

For more information: https://www.nejm.org/doi/full/10.1056/NEJMoa1809615

Enzo Life Sciences provides a wide range of products for all your Cancer research needs. Our platforms provide a wide range of small molecules, antibodies, and proteins including our PD-1 and PD-L1. Our SCREEN-WELL® Cancer Library provides a unique collection of 275 compounds. Our HER2/Neu monoclonal antibody provides a cost-effective opportunity for strong, clear staining with minimal background. Enzo’s immunohistochemistry reagents provide a complete set of tools for an efficient IHC process from start to finish.

Never miss a new TechNote!

Receive our TechNotes as soon as they are published.


 
comments powered by Disqus

Follow Us!

 

Related Products

PD-1 (human), (recombinant) 

Produced in HEK cells. Extracellular domain of PD-1 (aa 25-167) containing a 5’-His-tag, V5 epitope tag spacer, and a FLAG-tag., ≥90% (SDS-PAGE) | Print as PDF
 
ENZ-PRT190-0050 50 µg 307.00 USD
Do you need bulk/larger quantities?
 

PD-L1 (human), (recombinant) 

Produced in HEK cells. Human PD-L1 (aa 19-239) is fused at the N-terminus to a His-tag and FLAG®-tag., ≥90% (SDS-PAGE) | Print as PDF
 
ENZ-PRT223-0100 100 µg 480.00 USD
Do you need bulk/larger quantities?
 

PD-1 Recombinant monoclonal antibody (PDCD1/1410R) 

Flow Cytometry, IF, IHC (PS) | Print as PDF
 
ENZ-ABS348-0100 100 µg 440.00 USD
Do you need bulk/larger quantities?
 

PD-1 Recombinant monoclonal antibody (RMPD1-1) 

IF, IHC (PS) | Print as PDF
 
ENZ-ABS337-0100 100 µg 440.00 USD
Do you need bulk/larger quantities?
 

BRL-50481 

PDE inhibitor
433695-36-4, Synthetic., ≥98% (TLC) | Print as PDF
 
BML-PD120-0010 10 mg 80.00 USD
 
BML-PD120-0050 50 mg 307.00 USD
Do you need bulk/larger quantities?
 

Canertinib 

EFGR inhibitor
267243-28-7, ≥99% (HPLC) | Print as PDF
 
ENZ-CHM196-0005 5 mg 67.00 USD
 
ENZ-CHM196-0010 10 mg 99.00 USD
Do you need bulk/larger quantities?
 

HER2/Neu monoclonal antibody 

Monoclonal antibody to HER2 for use with IHC applications
IHC | Print as PDF
 
ENZ-ABS381-1000 1 ml Inquire for pricing
 
ENZ-ABS381-0100 100 µl Inquire for pricing
Do you need bulk/larger quantities?
 

SCREEN-WELL® Cancer Library 

Essential standards for cancer inhibitor screening
HTS | Print as PDF
 
ENZ-LIB102-0100 1 Library 100 µl/well Inquire for pricing
Do you need bulk/larger quantities?
 

Estrogen receptor monoclonal antibody (h-151) 

ICC, IP, WB | Print as PDF
 
ADI-SRA-1000-D 50 µg 175.00 USD
 
ADI-SRA-1000-F 200 µg 397.00 USD
Do you need bulk/larger quantities?
 

Estrogen receptor α monoclonal antibody (33) 

Flow Cytometry, ICC, IHC (FS), IHC (PS), IP, WB | Print as PDF
 
ALX-803-004-C050 50 µg 563.00 USD
Do you need bulk/larger quantities?
 

Progesterone ELISA kit 

ELISA, Colorimetric detection | Print as PDF
 
ADI-900-011 96 wells 295.00 USD
Do you need bulk/larger quantities?
 

p21 (human), ELISA kit 

ELISA, Colorimetric detection | Print as PDF
 
ADI-900-161 96 wells 573.00 USD
Do you need bulk/larger quantities?
 

SCREEN-WELL® FDA approved drug library V2 

Accelerates drug optimization with a unique collection of compounds of known safety and bioavailability for diverse targets.
HTS | Print as PDF
 
BML-2843-0100 1 Library 100 µl/well Inquire for pricing
Do you need bulk/larger quantities?
 

Estriol ELISA kit 

Certified for a large variety of sample types for steroid and hormone research.
ELISA, Colorimetric detection | Print as PDF
 
ADI-900-100 96 wells 272.00 USD
Do you need bulk/larger quantities?
 

17β-Estradiol high sensitivity ELISA kit 

Highly sensitive ELISA, detecting as little as 14 pg/ml of 17β-Estradiol
ELISA, Colorimetric detection | Print as PDF
 
ADI-900-174 96 wells 295.00 USD
Do you need bulk/larger quantities?
 

17β-Estradiol high sensitivity ELISA kit 

Highly sensitive ELISA, detecting as little as 14 pg/ml of 17β-Estradiol
ELISA, Colorimetric detection | Print as PDF
 
ADI-901-174 5x96 wells 1,179.00 USD
Do you need bulk/larger quantities?
 

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2018 Enzo Life Sciences, Inc.,